pharma news

News

Pfizer, Valneva shrug off phase 3 Lyme disease vaccine miss

Missing the primary endpoint in a phase 3 trial will not stop Pfizer from submitting Valneva-partnered Lyme disease vaccine for approval.

News

FDA seeks input into 'opaque' priority voucher scheme

FDA seeks public input on controversial priority voucher scheme amid concerns about its transparency and legality.

News

Dizal breaks new ground for EGFR drugs in lung cancer

Dizal's Zegfrovy has taken the oral EGFR inhibitor class into new territory, with a phase 3 win as a frontline treatment for a form of lung cancer.

News

After setback, Rhythm gets good news on Imcivree from FDA

Rhythm Pharma has secured the first approval in the US for a drug to treat hypothalamic obesity.

News

Novartis snaps up PI3Kα breast cancer drug in $3bn deal

Novartis has agreed to buy a PI3Kα-targeting drug for breast cancer from Synnovation, a potential successor to its Piqray brand, for $2bn upfront.

News

Appeal finds NICE must reconsider Alzheimer's drugs

Lilly and Eisai's bid to secure NHS coverage of their Alzheimer's therapies has entered a new phase, after an appeal of last year's rejection by NICE.

Pfizer, Valneva shrug off phase 3 Lyme disease vaccine miss

FDA seeks input into 'opaque' priority voucher scheme

Dizal breaks new ground for EGFR drugs in lung cancer

After setback, Rhythm gets good news on Imcivree from FDA

Novartis snaps up PI3Kα breast cancer drug in $3bn deal

Appeal finds NICE must reconsider Alzheimer's drugs

EMA seeks input on virtual alternative to animal test

Using AI-driven synthetic personas to take your insights fur...

pharma news

Editor's Picks